Riskpilot← Back to searchSign inGet full accessAKLINIKKEN NORGE AS
ASActiveOrg 916990812Skårersletta 18, 1473 LørenskogAllmenn legetjeneste · NACE 86211Est. 20160 employees
Revenue 2021
NOK 0
EBITDA margin
—
+20% vs 2020
Equity ratio
-48.3%
Financial strength
Net profit 2021
NOK 57K
-8% vs 2020
| Revenue | NOK 0 | — |
| EBITDA | NOK -83K | +20% |
| Net profit | NOK 57K | -8% |
| Total assets | NOK 723K | +148% |
| Equity | NOK -349K | +47% |
| Employees | 0 | — |
Legal name
AKLINIKKEN NORGE AS
Org number
916990812
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
8. april 2016
Share capital
NOK 50 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Drive legevirksomhet, legesentervirksomhet, undervisning og rådgivning, konsulentvirksomhet, herunder å eie andeler og aksjer i andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Skårersletta 18, 1473 Lørenskog
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 861 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −714 | −63 | 132 | −103 | −83 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −714 | −63 | 132 | −103 | −83 |
| Net financials | −992 | −6 | −10 | 164 | −1 |
| Profit before tax | −1 705 | −69 | 122 | 62 | −83 |
| Tax | −0 | −0 | −0 | −0 | −140 |
| Net profit | −1 705 | −69 | 122 | 62 | 57 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 38 | 0 | 127 | 291 | 723 |
| Equity | −1 016 | −845 | −723 | −655 | −349 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 054 | 845 | 849 | 946 | 1 072 |
| Total debt | 1 054 | 845 | 849 | 946 | 1 072 |
EBITDA margin
-8257700.0%
This company
15.8%
Market median
-52264024% vs market
20172021
Equity ratio
-48.3%
This company
38.2%
Market median
-226% vs market
20172021
Return on equity
5678700.0%
This company
18.4%
Market median
+30862400% vs market
20172021
Net profit margin
5678700.0%
This company
8.1%
Market median
+70107307% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
3.07×
This company
0.62×
Market median
-395% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AKLINIKKEN NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amir David Arden | Chairman | 0 companies |